Professor Thomas Richard Frazer Rogers
Fellow Emeritus, Clinical Microbiology
Biography
My main research interest is in invasive fungal infections, including molecular diagnostics, pathogenesis, host-pathogen interactions, and antifungal therapies. Also, research into nosocomial infections including Clostridium difficile colitis. Other current research includes study of Escherichia coli bacteraemia focusing on pathogenic mechanisms, epidemiology and antibiotic resistance.
Publications and Further Research Outputs
Peer-Reviewed Publications
Talento AF, Fitzgerald M, Redington B, O'Sullivan N, Fenelon N, Rogers TR, Prevention of healthcare-associated invasive aspergillosis during hospital construction/renovation works, Journal of Hospital Infection, 101, (1), 2019
Talento AF, Fitzgerald M, Redington B, O'Sullivan N, Fenelon N, Rogers TR, Prevention of healthcare-associated invasive aspergillosis during hospital construction/renovation works, Journal of Hospital Infection, 101, (1), 2019
Talento AF, Fitzgerald M, Redington B, O'Sullivan N, Fenelon N, Rogers TR, Prevention of healthcare-associated invasive aspergillosis during hospital construction/renovation works, Journal of Hospital Infection, 101, (1), 2019
Talento AF, Fitzgerald M, Redington B, O'Sullivan N, Fenelon N, Rogers TR, Prevention of healthcare-associated invasive aspergillosis during hospital construction/renovation works, Journal of Hospital Infection, 101, (1), 2019
Guinea J, Verweij PE, Meletiadis J, Mouton JW, Barchiesi F, Arendrup MC, How to: EUCAST recommendations on the screening procedure E.Def 10.1 for the detection of azole resistance in Aspergillus fumigatus isolates using four-well azole-containing agar plates., Clinical Microbiology and Infection, (9), 2018
Roycroft E, O'Toole RF, Fitzgibbon MM, Montgomery L, O'Meara M, Downes P, Jackson S, O'Donnell J, Laurenson IF, McLaughlin AM, Keane J, Rogers TR, Molecular epidemiology of multi and extensively drug-resistant Mycobacterium tuberculosis in Ireland, 2001-2004, Journal of Infection, 76, (1), 2018, p55 - 67
Dunne PJ, Maher CO, Freeley M, Dunne K, Petrasca A, Orikiiriza J, Dunne MR, Reidy D, O'Dea S, Loy A, Woo J, Long A, Rogers TR, Mulcahy F, Doherty DG, CD3" Expression Defines Functionally Distinct Subsets of V"1 T Cells in Patients With Human Immunodeficiency Virus Infection., Frontiers in Immunology, 2018
Talento AF, Dunne K, Murphy N, O'Connell B, Chan G, Joyce EA, Hagen F, Meis JF, Fahy R, Bacon L, Vandenberge E, Rogers TR, Post-influenzal triazole-resistant aspergillosis following allogeneic stem cell transplantation., Mycoses, 2018
Lynch M, Walsh TA, Marszalowska I, Webb AE, Mac Aogáin M, Rogers TR, Windle H, Kelleher D, O'Connell MJ, Loscher CE, Erratum to: Surface layer proteins from virulent Clostridium difficile ribotypes exhibit signatures of positive selection with consequences for innate immune response., BMC Evolutionary Biology, 17, (1), 2017, p135-
Talento AF , Dunne K , Joyce EA , Palmer M , Johnson E , White PL , Springer J, Loeffler J, Ryan T, Collins, Rogers TR, A prospective study of fungal biomarkers to improve management of invasive fungal diseases in a mixed specialty critical care unit., Journal of Critical Care, (40), 2017, p119 - 127
Mok S, Rogers TR , Fitzgibbon M., Evaluation of GenoType NTM-DR Assay for Identification of Mycobacterium chimaera., Journal of Clinical Microbiology, 55, (6), 2017, p1821 - 1826
Lynch M, Walsh TA, Marszalowska I, Webb AE, MacAogain M, Rogers TR, Windle H, Kelleher D, O'Connell MJ, Loscher CE., Surface layer proteins from virulent Clostridium difficile ribotypes exhibit signatures of positive selection with consequences for innate immune response., BMC Evolutionary Biology, 17, (1), 2017, p90 - 90
Dunne K , Hagen F , Pomeroy N , Meis J , Rogers TR, Inter-country transfer of triazole-resistant Aspergillus fumigatus on plant bulbs., Clinical Infectious Diseases, 65, (1), 2017, p147 - 149
Mac Aogáin M, Fennelly N, Walsh A, Lynagh Y, Bekaert M, Lawlor B, Walsh P , Kelly B, Rogers TR, Crowley B , Fourteen Draft Genome Sequences for the First Reported Cases of Azithromycin-Resistant Neisseria gonorrhoeae in Ireland., Genome Announcements, 5, (23), 2017
Barnes RA, White PL, Morton CO, Rogers TR, Cruciani M, Loeffler J, Donnelly JP, Diagnosis of aspergillosis by PCR: Clinical considerations and technical tips, Medical Mycology, 2017
Moloney G, Mac Aogáin M, Kelleghan M, O'Connell B, Hurley C, Montague E, Conlon M, Murray H, Rogers TR., Possible Interplay Between Hospital and Community Transmission of a Novel Clostridium Difficile Sequence Type 295 Recognized by Next-Generation Sequencing., Infection Control and Hospital Epidemiology, 37, (6), 2016, p680 - 684
Mac Aogáin M, Miajlovic H, Moloney G, Chotirmall SH, Rogers TR, Smith SG., Identification of a novel sequence type of Escherichia coli as the causative agent of pyelonephritis and bloodstream infection., JMM Case Reports, 3, (5), 2016
Teutschbein J, Simon S, Lother J, Springer J, Hortschansky P, Morton CO, Löffler J, Einsele H, Conneally E, Rogers TR, Guthke R, Brakhage AA, Kniemeyer O., Proteomic Profiling of Serological Responses to Aspergillus fumigatus Antigens in Patients with Invasive Aspergillosis., Journal of Proteome Research, 15, (5), 2016, p1580 - 1591
Arendrup MC, Meletiadis J, Mouton JW, Guinea J, Cuenca-Estrella M, Lagrou K, Howard SJ; Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST)., EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents., Clinical Microbiology and Infection, 22, (6), 2016, p571 - 571
Pankhurst LJ, Del Ojo Elias C, Votintseva AA, Walker TM, Cole K, Davies J, Fermont JM, Gascoyne-Binzi DM, Kohl TA, Kong C, Lemaitre N, Niemann S, Paul J, Rogers TR, Roycroft E, Smith EG, Supply P, Tang P, Wilcox MH, Wordsworth S, Wyllie D, Xu L, Crook DW, Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study., The Lancet. Respiratory medicine, 4, (1), 2016, p49-58
Preface in, editor(s)Mc Guckin, C. & L. Corcoran , Cyberbullying: where are we now? A cross-national understanding, Basel, Switzerland, MDPI AG, 2016, ppXI - XIII, [Mc Guckin, C. & Corcoran, L.]
Kinnevey PM, Shore AC, Mac Aogáin M, Creamer E, Brennan GI, Humphreys H, Rogers TR, O'Connell B, Coleman DC., Enhanced Tracking of Nosocomial Transmission of Endemic Sequence Type 22 Methicillin-Resistant Staphylococcus aureus Type IV Isolates among Patients and Environmental Sites by Use of Whole-Genome Sequencing., Journal of Clinical Microbiology, 54, (2), 2016, p445 - 448
Moloney G, O'Connell B, Rogers TR., Toxin Immunoassays and Clostridium difficile Infection., JAMA Internal Medicine, 176, (3), 2016, p413 - 414
McElroy MC, Hill M, Moloney G, Mac Aogáin M, McGettrick S, O'Doherty Á, Rogers TR., Typhlocolitis associated with Clostridium difficile ribotypes 078 and 110 in neonatal piglets from a commercial Irish pig herd., Irish Veterinary Journal, 69, (10), 2016
Mac Aogáin M, Kilkenny S, Walsh C, Lindsay S, Moloney G, Morris T, Jones S, Rogers TR., Identification of a novel mutation at the primary dimer interface of GyrA conferring fluoroquinolone resistance in Clostridium difficile., Journal of Global Antimicrobial Resistance, 3, (4), 2015, p295 - 299
Dunne K, Prior AR, Murphy K, Wall N, Leen G, Rogers TR, Elnazir B, Greally P, Renwick J, Murphy P, Emergence of persistent Aspergillus terreus colonisation in a child with cystic fibrosis., Medical mycology case reports, 9, 2015, p26-30
Brown AF, Murphy AG, Lalor SJ, Leech JM, O'Keeffe KM, Mac Aogáin M, O'Halloran DP, Lacey KA, Tavakol M, Hearnden CH, Fitzgerald-Hughes D, Humphreys H, Fennell JP, van Wamel WJ, Foster TJ, Geoghegan JA, Lavelle EC, Rogers TR, McLoughlin RM, Memory Th1 Cells Are Protective in Invasive Staphylococcus aureus Infection., PLoS pathogens, 11, (11), 2015, pe1005226
Mac Aogáin M, Moloney G, Kilkenny S, Kelleher M, Kelleghan M, Boyle B, Rogers TR, Whole-genome sequencing improves discrimination of relapse from reinfection and identifies transmission events among patients with recurrent Clostridium difficile infections., The Journal of hospital infection, 90, (2), 2015, p108-16
Maher CO, Dunne K, Comerford R, O'Dea S, Loy A, Woo J, Rogers TR, Mulcahy F, Dunne PJ, Doherty DG, Candida albicans stimulates IL-23 release by human dendritic cells and downstream IL-17 secretion by V"1 T cells., Journal of immunology (Baltimore, Md. : 1950), 194, (12), 2015, p5953-60
Miajlovic H, Mac Aogáin M, Collins CJ, Rogers TR, Smith SG, Characterization of Escherichia coli bloodstream isolates associated with mortality., Journal of medical microbiology, 2015
Lynagh Y, Mac Aogáin M, Walsh A, Rogers TR, Unemo M, Crowley B., Detailed characterization of the first high-level azithromycin-resistant Neisseria gonorrhoeae cases in Ireland., Journal of Antimicrobial Chemotherapy, 70, (8), 2015, p2411 - 2413
O'Driscoll C, Konjek J, Heym B, Fitzgibbon MM, Plant BJ, Ní Chróinín M, Mullane D, Lynch-Healy M, Corcoran GD, Schaffer K, Rogers TR, Prentice MB, Molecular epidemiology of Mycobacterium abscessus complex isolates in Ireland., Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2015
Micheál Mac Aogáin. Shauna Kilkenny, Claire Walsh, Sinéad Lindsay, Geraldine Moloney, Trefor Morris, Sophie Jones, Thomas R. Rogers, Identification of a novel mutation at the primary dimer interface of GyrA conferring fluoroquinolone resistance in Clostridium difficile, Journal of Global Antimicrobial Resistance, 2015
Abdolrasouli A, Rhodes J, Beale MA, Hagen F, Rogers TR, Chowdhary A, Meis JF, Armstrong-James D, Fisher MC, Genomic Context of Azole Resistance Mutations in Aspergillus fumigatus Determined Using Whole-Genome Sequencing., mBio, 6, (3), 2015, pe00536
O'Toole RF, Jackson S, Hanway A, O'Donnell J, Comiskey CM, Rogers TR, O'Flanagan D, Tuberculosis incidence in the Irish Traveller population in Ireland from 2002 to 2013., Epidemiology and infection, 2015, p1-7
Abdolrasouli A, Rhodes J, Beale MA, Hagen F, Rogers TR, Chowdhary A, Meis JF, Armstrong-James D, Fisher MC., Erratum for Abdolrasouli et al., Genomic Context of Azole Resistance Mutations in Aspergillus fumigatus Determined Using Whole-Genome Sequencing., mBio, 6, (4), 2015, pe00939
Miajlovic H, Cooke NM, Moran GP, Rogers TR, Smith SG., Response of Extraintestinal Pathogenic Escherichia coli to Human Serum Reveals a Protective Role for Rcs-Regulated Exopolysaccharide Colanic Acid., Infect Immun, 2014, p298 - 205
O'Toole RF, Johari BM, Mac Aogáin M, Rogers TR, Bower JE, Basu I, Freeman JT, Draft Genome Sequence of the First Isolate of Extensively Drug-Resistant Mycobacterium tuberculosis in New Zealand., Genome announcements, 2, (3), 2014
O'Toole RF, Johari BM, Mac Aogáin M, Rogers TR, Bower JE, Basu I, Freeman JT, Draft Genome Sequence of the First Isolate of Extensively Drug-Resistant Mycobacterium tuberculosis in New Zealand, Genome announcements, 2, (3), 2014
Brown AF, Leech JM, Rogers TR, McLoughlin RM, Staphylococcus aureus Colonization: Modulation of Host Immune Response and Impact on Human Vaccine Design., Frontiers in immunology, 4, 2014, p507
Miajlovic H, Cooke NM, Moran GP, Rogers TR, Smith SG, Response of extraintestinal pathogenic Escherichia coli to human serum reveals a protective role for Rcs-regylated exopolysaccharide colanic acid, Infection and Immunity, 82, 2014, p298 - 305
Morton CO, Fliesser M, Dittrich M, Mueller T, Bauer R, Kneitz S, Hope W, Rogers TR, Einsele H, Loeffler J., Gene expression profiles of human dendritic cells interacting with Aspergillus fumigatus in a bilayer model of the alveolar epithelium/endothelium interface., PLoS One, 9, (5), 2014, p1 - 12
Roycroft E, Mac Aogáin M, O'Toole RF, Fitzgibbon M, Rogers TR., Draft Genome Sequence of the First Isolate of Extensively Drug-Resistant Mycobacterium tuberculosis in Ireland., Genome announcements, 2014, ppii: e01002-14
Brown AF, Leech JM, Rogers TR, McLoughlin RM, Staphylococcus aureus colonization: modulation of host immune response and impact on vaccine design, Frontiers in Immunology, 4, 2014, p507-
Rogers TR, Morton CO, Springer J, Conneally E, Heinz W, Kenny, C, Frost S, Einsele H, Loeffler J, Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies, British Journal of Haematology, 161, 2013, p517 - 524
Ní Cheallaigh C, Fitzgerald I, Grace J, Jagjit Singh G, El-Eraki N, Gibbons N, Keane J, Rogers TR, Clarke S, Bergin C, Interferon Gamma Release Assays for the Diagnosis of Latent TB Infection in HIV-Infected Individuals in a Low TB Burden Country., PloS one, 8, (1), 2013, pe53330
Springer J, Morton CO, Perry M, Heinz WJ, Paholcsek M, Alzheimer M, Rogers TR, Barnes RA, Einsele H, Loeffler J, White PL, Multicenter comparison of serum and whole-blood specimens for detection of Aspergillus DNA in high-risk hematological patients., Journal of clinical microbiology, 51, (5), 2013, p1445-50
MM Fitzgibbon, N Gibbons, E Roycroft, S Jackson, J O'Donnell, D O'Flanagan, TR Rogers, A snapshot of genetic lineages of Mycobacterium tuberculosis in Ireland over a two-year period, 2010 and 2011, Eurosurveillance, 18, (3), 2013, p1 - 7
Collins, C.J., Rogers, T.R., Systemic antifungals, Infection Control in the Intensive Care Unit, 2013, p99-122
CO Morton, A de Luca, L Romani, TR Rogers, RT-qPCR detection of Aspergillus fumigatus RNA in vitro and in a murine model of invasive aspergillosis utilizing the PAXgene and Tempus RNA stabilization systems, Medical Mycology, 50, 2012, p661 - 666
F Walsh, TR Rogers, Comparison of plasmid mediated quinolone resistance and extended spectrum beta lactamases in third-generation cephalosporin resistant Enterobacteriaceae from four Irish hospitals, Journal of Medical Microbiology, 61, 2012, p142 - 147
McLaughlin AM, Gibbons N, Fitzgibbon M, Power JT, Foley SC, Hayes JP, Rogers T, Keane J, Primary Isoniazid Resistance in Mycobacterium bovis Disease: A Prospect of Concern., American Journal of Respiratory and Critical Care Medicine, 186, (1), 2012, p110-1
CO Morton, M Bouzani, J Loeffler, TR Rogers, Direct interaction studies between Aspergillus fumigatus and human immune cells; what have we learned about pathogenicity and host immunity?, Frontiers in Microbiology, 3, 2012, p1 - 6
Anthony Ryan, Mark Lynch, Sinead M. Smith, Sylvie Amu, Hendrik J. Nel, Claire E. McCoy, Jennifer K. Dowling, Eve Draper, Vincent O'Reilly, Ciara McCarthy, Julie O'Brien, Déirdre Ní Eidhin, Mary J. O'Connell, Brian Keogh, Charles O. Morton, Thomas R. Rogers, Padraic G. Fallon, Luke A. O'Neill, Dermot Kelleher, Christine E. Loscher , A Role for TLR4 in Clostridium difficile Infection and the Recognition of Surface Layer Proteins, PLoS Pathogens, 7, (6, e1002076), 2011
Rogers TR, Slavin MA, Donnelly JP, Antifungal prophylaxis during treatment for haematological malignancies: are we there yet?, British Journal of Haematology, 153, (6), 2011, p681 - 697
Morton CO, Clemons KV, Springer J, Mueller JG, Rogers TR, Stevens DA, Kurzai O, Einsele H, Loeffler J., Real-time PCR and quantitative culture for monitoring of experimental Aspergillus fumigatus intracranial infection in neutropenic mice, Journal of Medical Microbiology, E pub, 2011
Kullberg BJ, Verweij PE, Akova M, Arendrup MC, Bille J, Calandra T, Cuenca-Estrella M, Herbrecht R, Jacobs F, Kalin M, Kibbler CC, Lortholary O, Martino P, Meis JF, Muñoz P, Odds FC, De Pauw BE, Rex JH, Roilides E, Rogers TR, Ruhnke M, Ullman AJ, Uzun Ö, Vandewoude K, Vincent JL, Donnelly JP., European expert opinion on the management of invasive candidiasis in adults., Clinical Microbiology and Infection, 17, (Suppl. 5), 2011, p1 - 12
Morton CO, Varga JJ, Hornbach A, Mezger M, Sennefelder H, Kneitz S, Kurzai O, Krappmann S, Einsele H, Nierman WC, Rogers TR, Loeffler J, The temporal dynamics of differential gene expression in Aspergillus fumigatus interacting with human immature dendritic cells in vitro., PloS one, 6, (1), 2011, pe16016
Dunn K, O'Reilly A, Silke B, Rogers T, Bergin C, Implementing a pharmacist-led sequential antimicrobial therapy strategy: a controlled before-and-after study., International Journal of Clinical Pharmacy, 33, (2), 2011, p208-14
Cuenca-Estrella M, Bassetti M, Lass-Florl C, Racil Z, Richardson M, Rogers TR, Detection and investigation of invasive mould disease, Journal of Antimicrobial Chemotherapy, 66 Suppl 1, 2011, pi15 - i24
Walsh F, Cooke NM, Smith SG, Moran GP, Cooke FJ, Ivens A, Wain J, Rogers TR., Comparison of two DNA microarrays for detection of plasmid-mediated antimicrobial resistance and virulence factor genes in clinical isolates of Enterobacteriaceae and non-Enterobacteriaceae, International Journal of Antimicrobial Agents, pending, (pending), 2010
Morton CO, Loeffler J, De Luca A, Frost S, Kenny C, Duval S, Romani L, Rogers TR, Dynamics of extracellular release of Aspergillus fumigatus DNA and galactomannan during growth in blood and serum, Journal of Medical Microbiology, 59, 2010, p408 - 413
Springer J, Loeffler J, Heinz W, Schlossnagel H, Lehmann M, Morton O, Rogers TR, Schmitt C, Frosch M, Einsele H, Kurzai O., Pathogen specific DNA enrichment does not increase sensitivity of PCR for diagnosis of invasive aspergillosis in neutropenic patients, Journal of Clinical Microbiology, 2010
Cooke NM, Smith SG, Kelleher M, Rogers TR., Major differences exist in frequencies of virulence factors and multidrug resistance between community and nosocomial Escherichia coli bloodstream isolates., Journal of Clinical Microbiology, 48, 2010, p1099 - 1114
Rogers, T.R., Frost, S., Newer antifungal agents for invasive fungal infections in patients with haematological malignancy, British Journal of Haematology, 144, (5), 2009, p629-641
Armstrong-James, D.P.H., Turnbull, S.A., Teo, L., Stark, J., Rogers, N.J., Rogers, T.R.F., Bignell, E., Haynes, K., Impaired interferon-" responses, increased interleukin-17 expression, and a tumor necrosis factor-" transcriptional program in invasive aspergillosis, Journal of Infectious Diseases, 200, (8), 2009, p1341-1351
Armstrong-James DPH, Turnbull SA, Teo I, Stark J, Rogers NJ, Rogers TRF, Bignell E, Haynes K, Impaired interferon-gamma responses, increased interleukin-17 expression, and a tumor necrosis factor-alpha transcriptional program in inc=vasive aspergillosis, Journal of Infectious Diseases, 200, 2009, p1341 - 1351
Rogers, T.R., Treatment of zygomycosis: Current and new options, Journal of Antimicrobial Chemotherapy, 61, (SUPPL. 1), 2008, p35-40
Walsh, F. and T. R. Rogers., Detection of blaVIM-2 carbapenemase in Pseudomonas aeruginosa in Ireland., Journal of Antimicrobial Chemotherapy , 61, (1), 2008, p219 - 220
Hickson, M., D'Souza, A.L., Muthu, N., Rogers, T.R., Want, S., Rajkumar, C., Bulpitt, C.J., Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: Randomised double blind placebo controlled trial, British Medical Journal, 335, (7610), 2007, p80-83
Armstrong-James, D., Rogers, T., Microarray Technology for Studying the Virulence of Aspergillus Fumigatus, Medical Mycology: Cellular and Molecular Techniques, 2007, p257-273
Rogers, T.R., Antifungal drug resistance: limited data, dramatic impact?, International Journal of Antimicrobial Agents, 27, (SUPPL. 1), 2006, p7-11
Cooke GS, Cooke FJ, Stone M, Turner K, Al-Nahhas A, Win Z, Wain J, Rogers TR, Friedland JS, Bamford KB., Deep-seated resistance in relapsed paratyphoid fever., Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 42, (11), 2006, pe92-4
Calcagno AM,Bignell E,Rogers TR,Jones MD,Muhlschlegel FA,Haynes K,, Candida glabrata Ste11 is involved in adaptation to hypertonic stress, maintenance of wild-type levels of filamentation and plays a role in virulence. , Medical Mycology, 43, (4), 2005, p355 - 354
Bignell E,Negrete-Urtasun S,Calcagno AM,Arst HN Jr,Rogers T,Haynes K,, Virulence comparisons of Aspergillus nidulans mutants are confounded by the inflammatory response of p47phox-/- mice. , Infection and Immunity, 73, (8), 2005, p5204 - 5207
Wenzel R,Del Favero A,Kibbler C,Rogers T,Rotstein C,Mauskopf J,Morris S,Schlamm H,Troke P,Marciniak A,, Economic evaluation of voriconazole compared with conventional amphotericin B for the primary treatment of aspergillosis in immunocompromised patients. , Journal of Antimicrobial Chemotherapy, 55, (3), 2005, p352 - 361
Bignell E,Negrete-Urtasun S,Calcagno AM,Haynes K,Arst HN Jr,Rogers T,, The Aspergillus pH-responsive transcription factor PacC regulates virulence. , Molecular Microbiology, 55, (4), 2005, p1072 - 1084
Gothard P,Rogers TR,, Voriconazole for serious fungal infections, International Journal of Clinical Practice, 58, (1), 2004, p74 - 89
Krappmann S,Bignell EM,Reichard U,Rogers T,Haynes K,Braus GH,, The Aspergillus fumigatus transcriptional activator CpcA contributes significantly to the virulence of this fungal pathogen., Molecular Microbiology, 52, (3), 2004, p785 - 799
Pfaller MA,Barry A,Bille J,Brown S,Ellis D,Meis JF,Rennie R,Rinaldi M,Rogers T,Traczewski M,, Quality control limits for voriconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue, Journal of Clinical Microbiology, 42, (4), 2004, p1716 - 1718
Kamran M,Calcagno AM,Findon H,Bignell E,Jones MD,Warn P,Hopkins P,Denning DW,Butler G,Rogers T,Muhlschlegel FA,Haynes K,, Inactivation of transcription factor gene ACE2 in the fungal pathogen Candida glabrata results in hypervirulence. , Eukaryotic Cell, 3, (2), 2004, p546 - 552
Schrettl M,Bignell E,Kragl C,Joechl C,Rogers T,Arst HN Jr,Haynes K,Haas H,, Siderophore biosynthesis but not reductive iron assimilation is essential for Aspergillus fumigatus virulence, Journal of Experimental Medicine, 200, (9), 2004, p1213 - 1219
Calcagno AM,Bignell E,Rogers TR,Canedo M,Muhlschlegel FA,Haynes K,, Candida glabrata Ste20 is involved in maintaining cell wall integrity and adaptation to hypertonic stress, and is required for wild-type levels of virulence. , Yeast, 21, (7), 2004, p557 - 568
Cooke FJ,Terpos E,Boyle J,Rahemtulla A,Rogers TR,, Disseminated Aspergillus terreus infection arising from cutaneous inoculation treated with caspofungin. , Clinical Microbiology and Infection, 9 , (12), 2003, p1238 - 1241
Calcagno, A.-M., Bignell, E., Warn, P., Jones, M.D., Denning, D.W., Mühlschlegel, F.A., Rogers, T.R., Haynes, K., Candida glabrata STE12 is required for wild-type levels of virulence and nitrogen starvation induced filamentation, Molecular Microbiology, 50, (4), 2003, p1309-1318
Calcagno AM,Bignell E,Warn P,Jones MD,Denning DW,Muhlschlegel FA,Rogers TR,Haynes K,, Quality control limits for fluconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue. , Journal of Clinical Microbiology, 41, (8), 2003, p3410 - 3412
Barry A,Bille J,Brown S,Ellis D,Meis J,Pfaller M,Rennie R,Rinaldi M,Rogers T,Traczewski M,, Quality control limits for fluconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue. , Journal of Clinical Microbiology, 41, (7), 2003, p3410 - 3412
Dean, B., Lawson, W., Jacklin, A., Rogers, T., Azadian, B., Holmes, A., The use of serial point-prevalence studies to investigate hospital anti-infective prescribing, International Journal of Pharmacy Practice, 10, (2), 2002, p121-125
Rogers TR,, Antifungal drug resistance: does it matter? , International Journal of Infectious Disease, Mar 6 , (Suppl 1), 2002, pS47 - S53
Weig M,Haynes K,Rogers TR,Kurzai O,Frosch M,Muhlschlegel FA,, A GAS-like gene family in the pathogenic fungus Candida glabrata. , Microbiology, 147, (8), 2001, p2007 - 2019
Rogers, T.R., Optimal use of existing and new antifungal drugs, Current Opinion in Critical Care, 7, (4), 2001, p238-241
Barnes RA,Rogers TR,Pittet D,Burnie J,Haynes KA, Nosocomial fungal infection: diagnosis and typing. , Journal of Hospital Infection, 43 , (Suppl:), 1999, pS215 - S218
Holmes A,Jacklin A,Impallomeni M,Rogers TR,, Community-acquired pneumonia, Lancet, 353, (9163), 1999, p1528 - 1529
Woodhead, M., Mamun, M., Rogers, T., Wort, S.J., Community acquired pneumonia in elderly people (multiple letters) [7], British Medical Journal, 317, (7171), 1998, p1524-1525
Wort, S.J., Rogers, T.R., Community acquired pneumonia in elderly people, British Medical Journal, 316, (7146), 1998
Warnock DW,Johnson EM,Rogers TR,, Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy. , Journal of Antimicrobial Chemotherapy, 42, (3), 1998, p32 - 33`1
Vincent JL,Anaissie E,Bruining H,Demajo W,el-Ebiary M,Haber J,Hiramatsu Y,Nitenberg G,Nystrom PO,Pittet D,Rogers T,Sandven P,Sganga G,Schaller MD,Solomkin J,, Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. , Intensive Care Medicine, 24 , (3), 1998, p206 - 216
Wort SJ,Rogers TR,, Community acquired pneumonia in elderly people. Current British guidelines need revision. , British Medical Journal, 316, (7146), 1998, p1690 - 1690
Warnock, D.W., Johnson, E.M., Rogers, T.R.F., Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans, Journal of Antimicrobial Chemotherapy, 42, (3), 1998, p321-331
Jones, E.M., Kirkpatrick, B.L., Feeney, R., Reeves, D.S., MacGowan, A.P., Leung, D., Starr, J.M., Rogers, T.R., Impallomeni, M., Hospital-acquired Clostridium difficile diarrhoea (multiple letters) [14], Lancet, 349, (9059), 1997, p1176-1177
Barnes, R.A., Rogers, T.R.F., Cohen, J., Denning, D.W., Evans, E.G.V., Hay, R.J., Prentice, A.G., Speller, D.C.E., Warnock, D.W., Warren, R.E., Therapy of deep fungal infection in haematological malignancy, Journal of Antimicrobial Chemotherapy, 40, (6), 1997, p779-788
Edwards J.E., Jr., Bodey, G.P., Bowden, R.A., Buchner, T., De Pauw, B.E., Filler, S.G., Ghannoum, M.A., Glauser, M., Herbrecht, R., Kauffman, C.A., Kohno, S., Martino, P., Meunier, F., Mori, T., Pfaller, M.A., Rex, J.H., Rogers, T.R., Rubin, R.H., Solomkin, J., Viscoli, C., Walsh, T.J., White, M., Graybill, J.R., International conference for the development of a consensus on the management and prevention of severe candidal infections, Clinical Infectious Diseases, 25, (1), 1997, p43-62
Denning, D.W., Evans, E.G.V., Kibbler, C.C., Richardson, M.D., Roberts, M.M., Rogers, T.R., Warnock, D.W., Warren, R.E., Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation, European Journal of Clinical Microbiology and Infectious Diseases, 16, (6), 1997, p424-436
Starr, J.M., Rogers, T.R., Impallomeni, M., Hospital-acquired Clostridium difficile diarrhoea and herd immunity, Lancet, 349, (9049), 1997, p426-428
O'Donohoe, J.M., Sullivan, P.B., Scott, R., Rogers, T., Brueton, M.J., Barltrop, D., Recurrent abdominal pain and Helicobacter pylori in a community-based sample of London children, Acta Paediatrica, International Journal of Paediatrics, 85, (8), 1996, p961-964
Haynes KA, Tuinstra P, Hughes TA, Wijnands LM, Rogers TR, Allen AK., Purification and characterization of a 93 kDa Aspergillus fumigatus antigen with diagnostic potential., Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 34, (6), 1996, p421-426
Haynes, K.A., Tuinstra, P., Hughes, T.A., Wijnands, L.M., Rogers, T.R., Allen, A.K., Purification and characterization of a 93 kDa Aspergillus fumigatus antigen with diagnostic potential, Journal of Medical and Veterinary Mycology, 34, (6), 1996, p421-426
Haynes, K.A., Rogers, T.R., Clinical perspectives and diagnosis of invasive aspergillosis, Revista Iberoamericana de Micologia, 13, (SUPPL. 1), 1996
Barnes RA, Denning DW, Evans EG, Hay RJ, Kibbler CC, Prentice AG, Richardson MD, Roberts MM, Rogers TR, Speller DC, Warnock DW, Warren RE., Fungal infections: a survey of laboratory services for diagnosis and treatment., Communicable disease report. CDR review, 6, (5), 1996, pR69-75
Rothschild, E., Rauss, A., Danan, G., Lesna, M., Parham, D.M., Impallomeni, M., Starr, J., Rogers, T., Risk of diarrhoea due to Clostridium difficile during cefotaxime treatment [9], British Medical Journal, 312, (7033), 1996
Rogers, T., Rapid diagnosis of infection in the immunocompromised patient, Current Opinion in Infectious Diseases, 9, (4), 1996, p230-233
Denning, D.W., Evans, E.G.V., Kibbler, C.C., Richardson, M.D., Roberts, M.M., Rogers, T.R., Warnock, D.W., Warren, R.E., Fungal nail disease: A guide to good practice (report of a Working Group of the British Society for Medical Mycology), British Medical Journal, 311, (7015), 1995, p1277-1281
Rogers TR, Barnes RA, Denning DW, Evans EG, Hay RJ, Prentice AG, Speller DC, Warnock DW, Warren RE., Antifungal drug susceptibility testing. Working Party of the British Society for Antimicrobial chemotherapy., The Journal of antimicrobial chemotherapy, 36, (6), 1995, p899-909
Impallomeni M, Galletly NP, Wort SJ, Starr JM, Rogers TR., Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime., BMJ (Clinical research ed.), 311, (7016), 1995, p1345-1346
Rogers, T.R., Epidemiology and control of nosocomial fungal infections, Current Opinion in Infectious Diseases, 8, (4), 1995, p287-290
Speller DC, Lynn WA, Rogers TR., Glycopeptide Resistance in Gram-positive Bacteria., Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 1, (1), 1995, p54-59
Impallomeni, M., Galletly, N.P., Wort, S.J., Starr, J.M., Rogers, T.R., Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime, British Medical Journal, 311, (7016), 1995, p1345-1346
Denning DW, Evans EG, Kibbler CC, Richardson MD, Roberts MM, Rogers TR, Warnock DW, Warren RE., Fungal nail disease: a guide to good practice (report of a Working Group of the British Society for Medical Mycology)., BMJ (Clinical research ed.), 311, (7015), 1995, p1277-1281
Mulla RJ, Barnes E, Rogers TR., Is it time to stop using chloramphenicol on the eye? Fears are based on only six cases., BMJ (Clinical research ed.), 311, (7002), 1995, p450; author reply 451
Mulla, R.J., Barnes, E., Rogers, T.R., Buckley, R.J.K., Kirkness, C.M., Kanski, J.J., Ridgway, A.E.A., Tullo, A.B., Watson, P.G., Hall, A.V., Das, S.S., Tabaqchali, S., Cox, J., Roderick, E.M., Gordon-Smith, E.C., Marsh, J.C.W., Geary, C.G., Doona, M., Walsh, J.B., Is it time to stop using chloramphenicol on the eye? [1], British Medical Journal, 311, (7002), 1995, p450-451
Lynn, W.A., Clutterbuck, E., Want, S., Markides, V., Lacey, S., Rogers, T.R., Cohen, J., Treatment of CAPD-peritonitis due to glycopeptide-resistant Enterococcus faecium with quinupristin/dalfopristin, The Lancet, 344, (8928), 1994, p1025-1026
Nelson, M.R., Fisher, M., Cartledge, J., Rogers, T., Gazzard, B.G., The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection, AIDS, 8, (5), 1994, p651-654
Keating, J.J., Cartledge, J.D., Nelson, M., Hawkins, D.A., Gazzard, B.G., Rogers, T., Petrou, M., Woodrow, D., Management of pulmonary aspergillosis in AIDS: an emerging clinical problem, Journal of Clinical Pathology, 47, (9), 1994, p805-809
Haynes, K., Rogers, T.R., Retrospective evaluation of a latex agglutination test for diagnosis of invasive aspergillosis in immunocompromised patients, European Journal of Clinical Microbiology & Infectious Diseases, 13, (8), 1994, p670-674
Rogers, T.R., Nosocomial infections associated with bone marrow and other transplants, Current Opinion in Infectious Diseases, 7, (4), 1994, p484-487
Hart CA, Rogers TR., Meningococcal disease., Journal of medical microbiology, 39, (1), 1993, p3-25
Warren, R.E., Cohen, J., Denning, D.W., Hay, R.J., Mackenzie, D.W.R., Prentice, A.G., Rogers, T.R.F., Speller, D.C.E., Warren, R.E., Chemoprophylaxis for candidosis and aspergillosis in neutropenia and transplantation: A review and recommendations, Journal of Antimicrobial Chemotherapy, 32, (1), 1993, p5-21
Hart, C.A., Rogers, T.R.F., Meningococcal disease, Journal of Medical Microbiology, 39, (1), 1993, p3-25
Jurges E, Young Y, Eltumi M, Holliman RE, Vellodi A, Rogers TR, Hobbs JR., Transmission of toxoplasmosis by bone marrow transplant associated with Campath-1G., Bone marrow transplantation, 9, (1), 1992, p65-66
Haynes KA, Rogers TR, Latge JP, Barnes RA., Antigen detection in invasive aspergillosis., Clinical microbiology reviews, 5, (2), 1992, p211
Haynes, K.A., Rogers, T.R., Latge, J.P., Barnes, R.A., Kurup, V., Kumar, A., Antigen detection in invasive aspergillosis, Clinical Microbiology Reviews, 5, (2), 1992
Rogers TR., Virus infections complicating bone marrow transplantation., La Clinica terapeutica, 140, (2), 1992, p131-136
Roberts, G.D., Pfaller, M.A., Gueho, E., Rogers, T.R., De Vroey, C., Merz, W.G., Developments in the diagnostic mycology laboratory, Journal of Medical and Veterinary Mycology, Supplement, 30, (1), 1992, p241-248
Roberts GD, Pfaller MA, Gueho E, Rogers TR, De Vroey C, Merz WG., Developments in the diagnostic mycology laboratory., Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 30 Suppl 1, 1992, p241-248
Hyatt, D.S., Young, Y.M., Haynes, K.A., Taylor, J.M., McCarthy, D.M., Rogers, T.R., Rhinocerebral mucormycosis following bone marrow transplantation, Journal of Infection, 24, (1), 1992
Rogers, T.R., Infections complicating bone marrow transplantation, Current Opinion in Infectious Diseases, 4, (3), 1991, p370-374
Rogers, T.R.F., The Journal of Hospital Infection in the 1990s, Journal of Hospital Infection, 17, (1), 1991
Hyatt, D.S., Rogers, T.R.F., McCarthy, D.M., Samson, D.S., A randomized trial of ciprofloxacin plus azlocillin versus netilmicin plus azlocillin for the empirical treatment of fever in neutropenic patients[10], Journal of Antimicrobial Chemotherapy, 28, (2), 1991, p324-326
Rogers, T.R.F., Editorial statement: duplicate publication, Journal of Hospital Infection, 19, (1), 1991
Rogers TR., Prevention of infection during neutropenia., British journal of haematology, 79, (4), 1991, p544-549
Petrou, M.A., Rogers, T.R., Interactions in vitro between polyenes and imidazoles against yeasts, Journal of Antimicrobial Chemotherapy, 27, (4), 1991, p491-506
Petrou MA, Rogers TR., Interactions in vitro between polyenes and imidazoles against yeasts., The Journal of antimicrobial chemotherapy, 27, (4), 1991, p491-506
Hyatt DS, Rogers TR, McCarthy DM, Samson DS., A randomized trial of ciprofloxacin plus azlocillin versus netilmicin plus azlocillin for the empirical treatment of fever in neutropenic patients., The Journal of antimicrobial chemotherapy, 28, (2), 1991, p324-326
Rogers, T.R., Prevention of infection during neutropenia, British Journal of Haematology, 79, (4), 1991, p544-549
Haynes KA, Latge JP, Rogers TR., Detection of Aspergillus antigens associated with invasive infection., Journal of clinical microbiology, 28, (9), 1990, p2040-2044
Haynes, K.A., Latge, J.P., Rogers, T.R., Detection of Aspergillus antigens associated with invasive infection, Journal of Clinical Microbiology, 28, (9), 1990, p2040-2044
Rogers, T.R., Haynes, K.A., Barnes, R.A., Value of antigen detection in predicting invasive pulmonary aspergillosis, The Lancet, 336, (8725), 1990, p1210-1213
Barnes, R.A., Rogers, T.R., Control of an outbreak of nosocomial aspergillosis by laminar air-flow isolation, Journal of Hospital Infection, 14, (2), 1989, p89-94
Rogers, T.R., Infective complications of bone marrow transplantation, Current Opinion in Infectious Diseases, 2, (4), 1989, p578-581
Menzies D, Gilbert JM, Shepherd MJ, Rogers TR., A comparison between amoxycillin/clavulanate and mezlocillin in abdominal surgical prophylaxis., The Journal of antimicrobial chemotherapy, 24 Suppl B, 1989, p203-208
Cann KJ, Rogers TR., The phenotypic relationship of Neisseria polysaccharea to commensal and pathogenic Neisseria spp., Journal of medical microbiology, 29, (4), 1989, p251-254
Menzies, D., Gilbert, J.M., Shepherd, M.J., Rogers, T.R., A comparison between amoxycillin/clavulanate and mezlocillin in abdominal surgical prophylaxis, Journal of Antimicrobial Chemotherapy, 24, (SUPPL. B), 1989, p203-208
Cann, K.J., Rogers, T.R., Detection of antibodies to common antigens of pathogenic and commensal Neisseria species, Journal of Medical Microbiology, 30, (1), 1989, p23-31
Cann KJ, Rogers TR., Detection of antibodies to common antigens of pathogenic and commensal Neisseria species., Journal of medical microbiology, 30, (1), 1989, p23-31
Payne, C.M.E.R., Menday, A.P., Rogers, T., Staughton, R.C.D., Isoprinosine does not influence the natural history of herpes zoster or postherpetic neuralgia, Scandinavian Journal of Infectious Diseases, 21, (1), 1989, p15-18
Petrou MA, Rogers TR., In-vitro activity of antifungal agents in combination with four quinolones., Drugs under experimental and clinical research, 14, (1), 1988, p9-18
Rogers, T.R., Barnes, R.A., Prevention of airborne fungal infection in immunocompromised patients, Journal of Hospital Infection, 11, (SUPPL. A), 1988, p15-20
Cann, K.J., Watkins, R.M., George, C., Payne-James, J., Crawfurd, E., Rogers, T.R., A trial of mezlocillin versus cefuroxime with or without metronidazole for the prevention of wound sepsis after biliary and gastrointestinal surgery, Journal of Hospital Infection, 12, (3), 1988, p207-214
Petrou, M.A., Rogers, T.R., In-vitro activity of antifungal agents in combination with four quinolones, Drugs under Experimental and Clinical Research, 14, (1), 1988, p9-18
Petrou MA, Rogers TR., The inhibitory effect of serum on the growth of Torulopsis glabrata., Journal of medical microbiology, 25, (3), 1988, p213-220
Barnes, R.A., Rogers, T.R., Response rates to a staged antibiotic regimen in febrile neutropenic patients, Journal of Antimicrobial Chemotherapy, 22, (5), 1988, p759-763
Petrou, M.A., Rogers, T.R., The inhibitory effect of serum on the growth of Torulopsis glabrata, Journal of Medical Microbiology, 25, (3), 1988, p213-220
Rogers, T.R., Infective complications of bone marrow transplantation, Current Opinion in Infectious Diseases, 1, (4), 1988, p616-624
Barnes RA, Rogers TR., Response rates to a staged antibiotic regimen in febrile neutropenic patients., The Journal of antimicrobial chemotherapy, 22, (5), 1988, p759-763
Cann, K.J., Rogers, T.R., Jones, D.M., Noah, N.D., Burns, C., Neisseria meningitidis in a primary school, Archives of Disease in Childhood, 62, (11), 1987, p1113-1117
Barnes, R.A., Rogers, T.R., An evaluation of empirical antibiotic therapy in febrile neutropenic patients, British Journal of Haematology, 66, (1), 1987, p137-140
Barnes RA, Rogers TR., An evaluation of empirical antibiotic therapy in febrile neutropenic patients., British journal of haematology, 66, (1), 1987, p137-140
Rogers, T.R., Annotation. Investigation of infection in immunocompromised patients, British Journal of Haematology, 61, (2), 1985, p195-201
Rogers TR., Investigation of infection in immunocompromised patients., British journal of haematology, 61, (2), 1985, p195-201
Petrou, M.A., Rogers, T.R., A comparison of the activity of mepartricin and amphotericin B against yeasts, Journal of Antimicrobial Chemotherapy, 16, (2), 1985, p169-177
Jones, S.A.M., Miller, H.J., Rogers, T.R., Kirk, N.R., Dulake, C., Zamiri, I., An experience of diphtheria in Westminster, Public Health, 98, (1), 1984, p3-7
Phua, T.J., Rogers, T.R., Pallett, A.P., Prospective study of Clostridium difficile colonization and paracresol detection in the stools of babies on a special care unit, Journal of Hygiene, 93, (1), 1984, p17-25
Rogers, T.R., Petrou, M., Lucas, C., Chung, J.T., Barrett, A.J., Borriello, S.P., Honour, P., Spread of Clostridium difficile among patients receiving non-absorbable antibiotics for gut decontamination, British Medical Journal, 283, (6288), 1981, p408-409
Teare EL, Bakhtiar M, Rogers TR, Oates JK., Non-specific vaginitis: its diagnosis and treatment., The Journal of antimicrobial chemotherapy, 8, (6), 1981, p496-497
Rogers TR, Petrou M, Lucas C, Chung JT, Barrett AJ, Borriello SP, Honour P., Spread of Clostridium difficile among patients receiving non-absorbable antibiotics for gut decontamination., British medical journal (Clinical research ed.), 283, (6288), 1981, p408-409
Teare, E.L., Bakhtiar, M., Rogers, T.R., Oates, J.K., Non-specific vaginitis: Its diagnosis and treatment, Journal of Antimicrobial Chemotherapy, 8, (6), 1981, p496-497
Rogers, T.R., Problems with cytomegalovirus in hospital practice, Journal of Hospital Infection, 1, (4), 1980, p281-283
Selwyn, S., Anderson, I.S., Rogers, T.R., Quantitative studies on the decontamination of skin and mucous membranes in relation to immunodeficient patients, Zentralblatt fur Bakteriologie Mikrobiologie und Hygiene - Abt. 1 Orig. A, 245, (Suppl. 7), 1979, p281-284
Walker TM, Merker M, Knoblauch AM, Helbing P, Schoch OD, van der Werf MJ, Kranzer K, Fiebig L, Kröger S, Haas W, Hoffman H, Indra A, Egli A, Cirillo DM, Robert J, Rogers TR, Groenheit R, Mengshoel AT, Mathys V, Haanperä M, Soolingen DV, Neimann S, Böttger EC, Keller PM, MDR-TB Cluster Consortium., A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study, Lancet Infectious Diseases
Non-Peer-Reviewed Publications
Mac Aogáin M, Roycroft E, Raftery P, Mok S, Fitzgibbon M, Rogers TR., Draft Genome Sequences of Three Mycobacterium chimaera Respiratory Isolates., Genome Announcements, 3, (6), 2015
Mac Aogáin M, Rogers TR, Crowley B., Identification of emergent bla CMY-2 -carrying Proteus mirabilis lineages by whole-genome sequencing., New Microbes and New Infections, 27, (9), 2015, p58 - 62
Research Expertise
Description
Infections in immunocompromised hosts. Invasive fungal infections. Antifungal therapy. Host pathogen interactions. Escherichia coli bloodstream infection. Antibiotic resistance. Nosocomial infections. Epidemiology of tuberculosis. Diagnostic tests for tuberculosis.Projects
- Title
- Evaluation of next generation sequencing to investigate the epidemiology of Clostridium difficile infection
- Summary
- A prospective study of C difficile infection in hospitalised patients using next generation sequencing as a tool to provide high level discrimination between strains. An additional theme will be investigation of the intestinal microbiota in selected patients with C difficile infection
- Funding Agency
- Health Research Board
- Date From
- September 2014
- Date To
- August 2017
- Title
- Development of novel management strategies for invasive aspergillosis "MANASP"
- Summary
- Development of novel molecular diagnostics for invasive aspergillosis. Study of DNA release from Aspergillus fumigatus during in vitro growth and correlation with dynamics of DNA release during experimental infections in vivo. Study of Aspergillus fumigatus-human dendritic cells interaction ex vivo. Study of A fumigatus-human monocytes interaction ex vivo. Investigation of immunologically important Aspergillus antigens produced in human serum during invasive aspergillosis
- Funding Agency
- European Union
- Date From
- 2006
- Date To
- 2010
Recognition
Memberships
President of the Healthcare Infection Society
President Irish Fungal Society